Home
About
Share This
Set as HomepageWyeth
Wyeth® Antivenin (Micrurusfulvius)
1 A.H.F.S. Category 80:04 Wyeth ® Antivenin (Micrurusfulvius) (Equine Origin) North American Coral SnakeAntivenin Composition Antivenin (Micrurusfulvius), Wyeth, is a refined, concentrated, and lyophilized preparation of serum globulins obtained by fractionating blood from healthy horses that ...
HIGHLIGHTS OF PRESCRIBING INFORMATION
(6.1) To report SUSPECTED ADVERSE REACTIONS, contact Wyeth Pharmaceuticals Inc. at 1-800-934-5556 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch ———————USE IN SPECIFIC POPULATIONS ...
QUESTIONS AND ANSWERS CONCERNING EXCHANGING WYETH COMMON STOCK
QUESTIONS AND ANSWERS CONCERNING EXCHANGING WYETH COMMON STOCK Tax-Related: 1. Since the transaction is fully taxable, how will the Company report my merger consideration for tax purposes?
Pfizer Factor Savings Card Program
Pfizer Factor Savings Card Program If you are using a nonparticipating provider, you can still take advantage of this program, if eligible, on your next order of factor.
ABUS0X0617 IVBag PhamrLtr r25 PDF Release
Re: ZYVOX ® IV Injection (linezolid) announcement of new FreeFlex ® IV bag Dear Valued Customer, The purpose of this letter is to inform you that ZYVOX IV Injection will transition from the currently used Excel
Pfizer Completes Acquisition Of Wyeth
For immediate release: Media Contact: October 15, 2009 Joan Campion (212) 733-2798 Investor Contact: Suzanne Harnett (212) 733-8009 Pfizer Completes Acquisition Of Wyeth NEW YORK, NY, October 15 - Pfizer (NYSE: PFE) and Wyeth (NYSE: WYE) announced today that Pfizer has completed its acquisition ...
Wyeth and Elan Begin Phase 3 Program for Bapineuzumab (AAB ...
Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial of Bapineuzumab at International Conference on Alzheimer's Disease Wyeth and Elan Begin Phase 3 Program for Bapineuzumab (AAB-001) in Alzheimer’s Disease
The following discussion sets forth the material U.S. federal ...
Material U.S. Federal Income Tax Consequences of the Merger The following discussion sets forth the material U.S. federal income tax consequences of the merger to U.S. holders (as defined below) of Wyeth common stock that exchange their Wyeth common stock for Pfizer common stock and cash.
09-152 Bruesewitz v. Wyeth LLC (02/22/11)
1 (Slip Opinion) OCTOBER TERM, 2010 Syllabus NOTE: Where it is feasible, a syllabus (headnote) will be released, as is being done in connection with this case, at the time the opinion is issued.
Stock Split
WYE Historical Stock Price Dividend Information.xls. Wyeth's historical stock prices and split history are provided by Bloomberg LP.
